Literature DB >> 7189268

Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea.

M C Nunes, L G Sobrinho, C Calhaz-Jorge, M A Santos, J C Mauricio, M F Sousa.   

Abstract

A biographic and clinical investigation of 101 patients with hyperprolactinemia and/or galactorrhea is reported. Fifty-one patients were reared without their fathers and 18 with an alcoholic, violent one. These situations were uncommon in the control population, and the differences were statistically significant. There was a high frequency of complaints of obesity, headaches, frigidity, lightheadedness, and fullness of the abdomen, limbs, or face. There was a significant temporal correlation of external events in the natural history with onset or worsening of the symptoms. It is concluded that exposure during childhood to an environment characterized by an absent or alcoholic, violent father conditions some women to develop hyperprolactinemia and/or galactorrhea later in life as a response to specific environmental changes. These conclusions apply similarly to patients with prolactinoma, idiopathic hyperprolactinemia, and euprolactinemic galactorrhea, suggesting a close relationship among the 3 entities.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189268

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  A case of galactorrhea with escitalopram: a biopsychosocial phenomenon.

Authors:  Rahul S Bharadwaj; Teresa B Slade
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas.

Authors:  L G Sobrinho; J S Duarte; I Paiva; L Gomes; V Vicente; P Aguiar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 3.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

4.  Quality of life in women with microprolactinoma treated with dopamine agonists.

Authors:  Erika Cesar de Oliveira Naliato; Alice Helena Dutra Violante; Dayse Caldas; Adilson Lamounier Filho; Christiane Rezende Loureiro; Rosita Fontes; Yolanda Schrank; Rodrigo Gomes de Souza; Mario Vaisman; Ermelinda Guerra; Arantzazu Sebastian; Annamaria Colao
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 5.  Prolactin, psychological stress and environment in humans: adaptation and maladaptation.

Authors:  Luis Gonçalves Sobrinho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Psychosomatic aspects of galactorrhea.

Authors:  M Langer; J Fiegl; V Riegel; R Prohaska; E Kubista; M Ringler
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

Review 7.  Leptin and leptin receptor in anterior pituitary function.

Authors:  R V Lloyd; L Jin; I Tsumanuma; S Vidal; K Kovacs; E Horvath; B W Scheithauer; M E Couce; B Burguera
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

8.  A rare adverse drug reaction to escitalopram.

Authors:  Monika Pathania; Bhomik Goel; Puneet Dhamija; Ravi Kant; Minakshi Dhar; Sunita Mittal
Journal:  J Family Med Prim Care       Date:  2018 Mar-Apr

9.  Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia.

Authors:  Fuyin Yang; Lan Chen; Xinyu Fang; Ke Zheng; Cheng Zhu; Chaoqun Xu; Chen Zhang; Wei Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-13       Impact factor: 2.570

10.  Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline.

Authors:  Nazir A Pala; Bashir A Laway; Raiz A Misgar; Rayees A Dar
Journal:  Diabetol Metab Syndr       Date:  2015-11-14       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.